Updates are available Correction dated 2018-03-08
Click to view Correction: https://doi.org/10.1186/s12885-018-4128-9
-
Authors
Mörén, Lina
Perryman, Richard
Crook, Tim
Langer, Julia K.
Oneill, Kevin
Syed, Nelofer
Antti, Henrik http://orcid.org/0000-0003-1423-9517
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2014-04495)
Cancerfonden (14 0431)
Brain Tumour Research Campaign (295895)
-
More Information
Article History
Received: 23 July 2016
Accepted: 23 January 2018
First Online: 8 February 2018
Change Date: 8 March 2018
Change Type: Correction
Change Details: In the original publication of this article [1], published on 8 February 2018, it was noticed that the acknowledgement of the source of the drug ADI-PEG20 was missing.
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
